BioHealth News Archive
Adaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management | Business Wire
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced the appointment of…
Read More
DC Region’s Life Sciences Sector Is on the Rise – Commercial Observer
Go pakh your cahr, Boston. Grab some granola, California. It’s D.C.’s moment in life sciences. For years, the Washington metropolitan area has been one…
Read More
Startup Professionals Musings: 6 New Venture Realities To Target Your Funding Effort
Entrepreneurs who require funding for their startup have long counted on self-accredited high net worth individuals (“angels”) to fill their needs, after friends and…
Read More
My View: Angel investor extension means business for Arizona – Phoenix Business Journal
Since 2005, the Small Business Capital Investment Incentive has generated early-stage funding for more than 200 Arizona businesses, including my company, Qwick. I moved…
Read MoreMeacham: The DNA of entrepreneurship
Of the nearly 3 billion base pairs in the human genome, about 99% are the same in every human being — however, it is…
Read More
Open Positins at BD
BD is a leading global medical technology company that creates medical technology, devices and laboratory equipment for a variety of needs across the healthcare…
Read More
Cartesian Therapeutics President & Chief Executive Officer, Murat Kalayoglu, MD, PhD, Returns to BioTalk
Dr. Murat Kalayoglu, President and CEO at Cartesian Therapeutics, provides an update since his last visit on their cell and gene therapies, as well…
Read More
New rapid COVID testing options coming to Delta; Purchase and pack for smooth U.S. re-entry | Delta News Hub
Delta customers now have more ways to meet COVID-19 test requirements introduced by the U.S. Centers for Disease Control and many international governments during…
Read More
Cloud’s trillion-dollar prize is up for grabs | McKinsey
Moderna CEO Stéphane Bancel made the decision to build his mRNA research-and-development platform on public cloud to create what he calls “software for life.”1…
Read More
Emmes Selected as an Area Top Workplace by The Washington Post for a Fifth Year | Emmes
Emmes today announced that it was selected as one of the best places to work in the greater Washington area. This is the fifth…
Read More
More than 290 biotech leaders sign declaration in favor of preserving IP rights
Many of you are following the ongoing effort by some political leaders to strip our scientific intellectual property rights pertaining to vaccines and treatments…
Read More
Children’s National scientists shortlisted for funding | Children’s National
A diverse, global team of scientists, led by University College of London and Children’s National Hospital/George Washington University, has been selected for the final stages of Cancer…
Read More
Aifred Health is #2 in the WORLD in the Global @IBM Watson AI XPRIZE!
It is with enormous pride and excitement that we announce that Aifred Health is #2 in the WORLD in the Global @IBM Watson AI XPRIZE! I could not be…
Read More
CEO Talks Series, featuring Immunomic CEO Bill Hearl
UNITE, A comprehensive immuno-oncology approach }https://www.youtube.com/watch?v=HmkDu4qK2aM
Read More
How Did Silicon Valley Become Silicon Valley? by Endeavor – issuu
Three Surprising Lessons for Other Cities and Regions. Download the PDF: http://share.endeavor.org/pdf/HDSVBSV.pdf {iframe}https://issuu.com/endeavorglobal1/docs/hdsvbsv__final_{/iframe}
Read More